In the present study, our results demonstrated that miR-106b activated the MAPK signaling pathway, while NR2F2-AS1 and PLEKHO2 inhibited the MAPK signaling pathway in CRC. The gene discussed is PLEKHO2; the disease is colorectal carcinoma.